US Pharma MarketingA different approach to lowering healthcare costs
Garner Health sits somewhere between care navigation companies that steer you to certain providers, and alternative health plans taking their own swings at lowering employers’ costs — often with the help of more focused provider networks or various approaches to payments Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy…
Last month, Garner Health raised $100 million, vaulting its valuation to $2.7 billion.
At first, this startup sounded more like a doctor-rankings company, which I’d typically think of as more ...
Source: Endpoints News